Contact tracing
When a family or community refuses to talk to a health team, at-risk contacts remain outside the 21-day monitoring window and chains of transmission are harder to interrupt.
Rumours, misinformation and disinformation narratives around Ebola are not a marginal problem. In past epidemics they undermined trust, delayed people seeking care, and in the DRC contributed to tension around health teams. The current outbreak repeats familiar motifs: an alleged hoax, a laboratory origin, a biological weapon, a “planned crisis”, miracle cures, refusal of hospitals, and the misuse of old or decontextualised footage.
How rumours spread and why they matter
In the affected areas this is not just about online content. Rumours spread through a combination of word of mouth in communities, WhatsApp, TikTok, Facebook, YouTube comments, X/Twitter and local languages. In a setting of conflict, displacement and long-standing distrust of the state and of outsiders, they can have a direct impact on the response: people may hide the sick, refuse contact tracing, obstruct safe burials, or avoid treatment centres.
Safe burials
The body of a deceased person can be highly infectious. Rumours about burial teams or burial bans therefore increase the risk of dangerous contact with the body of the deceased.
Care and isolation
Fear of hospitals, injections or “foreign” health workers can lead to late presentation for care, the use of unproven remedies and further transmission within the household.
The most common narratives
“It is all staged”
Typically this uses old or decontextualised photographs of health workers in protective suits. In the local context this narrative can take the form of claims that Ebola does not exist, that the deaths have a mystical cause, or that the disease is being invented for money. The response should rest on primary sources, laboratory confirmation and a clear separation of verified cases from rumours.
“It is a laboratory-made virus”
The available sequencing data support a new zoonotic introduction of the known Bundibugyo virus (BDBV); no evidence of a laboratory origin has been presented.
“The virus mutated, which is why the outbreak is so large”
This has not been established. On 6 August, media reports quoted the Africa CDC director-general as saying that studies were only being planned to examine a possible link between unusual severity and viral changes. Viruses routinely change genetically as they replicate, but public sequence records and the new WHO report do not by themselves demonstrate a mutation increasing transmissibility or severity. WHO describes an expansion phase and the second-largest Ebola outbreak in history, not a confirmed dangerous mutation.
“A simple remedy is enough”
Ivermectin, turmeric, vitamin mixtures, baking soda, alcohol and “alkalisation” do not cure Ebola. Such claims can delay isolation and real care; for Bundibugyo the mainstays remain early isolation, supportive care, protection of health workers and the clinical evaluation of candidate products. PARTNERS evaluates MBP134 and remdesivir, and from 14 July EBO-PEP evaluates obeldesivir as post-exposure prophylaxis. Neither is approved, routinely available treatment or prophylaxis.
“A vaccine exists, but it is being kept secret”
Ervebo is licensed for Ebola virus (EBOV), not BDBV. WHO's June vaccine Q&A did not recommend its use in BDBV outbreaks; after newer expert review, WHO and Africa CDC announced on 20 August an allocation of 20,000 doses for a Phase III trial and 50,000 for health and frontline workers. Whether Ervebo protects humans against BDBV is unknown; WHO says it is essential to provide information about risks, possible benefits and limitations and enable informed consent. The allocation is not licensing or proof of efficacy against BDBV.
“A new test means the disease was made in a laboratory”
No. On 2 July, WHO added the first molecular diagnostic test for BDBV to its Emergency Use Listing to speed reliable laboratory case detection, clinical care and surveillance. This is diagnostics for a known Bundibugyo virus, not evidence of laboratory origin and not a treatment.
“Hospitals or injections are more dangerous than the disease”
This narrative discourages isolation and care. Yet for Ebola, early detection, separation of the patient from further contacts, hydration, treatment of complications and protection of health workers are essential even where there is no specific approved treatment for the given ebolavirus.
“The crisis serves mining, control or profit”
Economic and political grievances in the affected region are a real context for distrust, but they do not in themselves prove that the outbreak is deliberately manufactured or invented. For a public-facing text it is safer to write about an anti-Western and anti-institutional narrative than to repeat individual unsubstantiated accusations.
“Transfer to the Czech Republic means a case of Ebola in Czechia”
No. Precautionary isolation of an at-risk contact or of a person after a stay in an at-risk area does not mean a confirmed case or community transmission.
“Ebola is already in France and Germany, so it is spreading across Europe”
Not in that way. The French patient was an imported case after returning from the DRC and WHO lists the patient as recovered. The second US patient admitted in Frankfurt on 13 July was infected in the DRC and medically evacuated under controlled conditions. Neither event is evidence of community transmission in Europe; ECDC continues to assess the likelihood of infection for people living in the EU/EEA as very low.
“Ebola spreads like COVID”
It does not spread through the air like a common respiratory infection. The risk is contact with the bodily fluids of a sick or deceased person, or with contaminated objects.
“CDC predicted 20,000 cases”
It cannot be put that way. On 5 June, CDC published modelled scenarios, not a certain prediction. The results change substantially depending on how quickly cases are found and isolated.
“A jump in the figures means dozens of new infections a day”
Not necessarily. For the DRC, WHO points out that newly reported confirmed cases and deaths may be linked to the retrospective processing of previously unevaluated samples and to data harmonisation, not necessarily to freshly acquired infections.
“Uganda is already past the outbreak”
At national level, yes: on 28 July Uganda's Ministry of Health announced that the country was “officially Ebola free”, and ECDC records that declaration. On 18 August, WHO stated publicly that Uganda had stopped transmission, and report 14 records 31 days without a new confirmed case. A separate formal WHO statement confirming the exact 28 July declaration was not located. Transmission in the DRC and the PHEIC continue.
“You cannot travel out of Uganda without a certificate”
On 16 June, the Ugandan Ministry of Health stated that travellers leaving Uganda do not need an “Ebola-Free Certificate”. Testing is to be based on symptoms, contact with a confirmed case, and the assessment of health authorities.
“US entry restrictions mean a new pandemic”
No. On 21 June, CDC stated the continuation of temporary entry restrictions and entry screening for selected people after a stay in the DRC, Uganda or South Sudan. This is a US national travel rule, not evidence of a pandemic or of a change in how BDBV is transmitted.
“Health workers are spreading Ebola”
No. On 17 June, ECDC flagged a report of an attack on a safe and dignified burial team in Mongbwalu and reports that five workers at entry or screening points had been detained after a false accusation of spreading Ebola. Such claims jeopardise contact tracing, isolation and safe burials.
The Czech context
In the Czech setting, during the 26 August check the main concerns involved the woman assessed after returning from Uganda, Bulovka, Těchonín and the European patients. Communication must keep the categories separate: laboratory testing ruled out Ebola in the Czech woman on 2 August; other people were precautionarily isolated after a risk contact or return; confirmed patients were infected in the DRC and treated in Berlin, Frankfurt or France. No confirmed Ebola case or community transmission has been publicly reported in the Czech Republic.
On 13 July, UNICEF published results from a May survey of approximately 50,000 U-Report respondents in the DRC: 64% did not understand how the disease was transmitted, 63% did not know how to protect themselves, and around one in five did not believe the disease existed. These are newly published results from older May data collection, not the epidemiological status as of 13 July.
According to the monitoring of public sources so far, neither Czechia, Slovakia nor Poland is the source of a significant local campaign around this outbreak. What predominates is ordinary news coverage of the situation in Africa, the low risk for Europe and national preparedness. The risk lies more in the marginal uptake of global narratives: a laboratory origin, “Big Pharma”, a secret vaccine, migration, military facilities or distrust of health institutions. Individual social-media posts do not in themselves prove a coordinated campaign, however.
How to respond briefly
| Claim | Short answer |
|---|---|
| “We have Ebola in Czechia.” | Not according to the available information. Laboratory testing ruled out the suspected case in the woman returning from Uganda on 2 August. Precautionary isolation and transfer under controlled conditions are not a confirmed case or community transmission. |
| “The doctor in Germany had no symptoms.” | No. The Berlin patient was confirmed infected and had symptoms; it was his family contacts and the Czech precautionarily monitored people who were symptom-free. |
| “There is already a vaccine for Ebola, so why the panic?” | The Ervebo vaccine is for Ebola virus (EBOV). The current outbreak is caused by Bundibugyo virus and there is as yet no specific approved vaccine. Starting a Phase I trial of the ChAdOx1 BDBV vaccine candidate is not the same as an available licensed vaccine. |
| “This is a new pandemic.” | WHO has declared a PHEIC; it also stated that the event does not meet the criteria for a “pandemic emergency” under the International Health Regulations. |
| “We are automatically facing an epidemic of tens of thousands.” | The CDC modelled scenarios show why rapid isolation is crucial. They are not certain counts of future cases. |
| “The DRC had dozens of newly infected people in a day.” | Cautiously: part of the reported increase may be linked to the retrospective processing of previously unevaluated samples and to data harmonisation. It is correct to say “newly reported”, not automatically “newly infected”. |
| “If there are no new cases in Uganda, the risk is over.” | Not automatically. Uganda announced the end of the outbreak on 28 July, but the DRC continues to report community transmission. A new imported or linked case would require renewed investigation and appropriate response measures. |
| “People don’t trust the teams because the teams spread the disease.” | Distrust is a real operational problem, but it is not evidence that health workers spread the disease. Refusing contact tracing, isolation and safe burials can in fact worsen transmission. |
| “Herbs, alcohol or home-made mixtures are enough.” | No. Unproven remedies can delay isolation and supportive care. For Bundibugyo there are no approved specific vaccines or targeted treatment; that is precisely why rapid detection, isolation, expert care and protocol-based clinical evaluation of candidates are important. |
| “WHO has approved a new drug or vaccine.” | No. On 2 July, WHO announced patient enrolment in the PARTNERS trial and emergency listing of the first molecular diagnostic test for BDBV. That is a clinical trial and diagnostics, not an approved treatment or vaccine. |
| “This is a pretext for mining or profit.” | Political and economic distrust in the region is an important context, but it does not in itself prove that the outbreak is invented or deliberately manufactured. What is verified are the cases, deaths, laboratory diagnostics and public sequencing data. |
| “Uganda requires proof that a person does not have Ebola.” | Not as a general condition of travel. On 16 June, Uganda stated that an “Ebola-Free Certificate” is not needed either to leave Uganda or for visa applications to other countries. |
| “If the USA is tightening entry, it must be a pandemic.” | No. The US entry restriction and entry screening are national measures for selected travellers after a stay in the DRC, Uganda or South Sudan. WHO has declared a PHEIC, not a pandemic, and ECDC continues to assess the risk for the general EU/EEA population as very low. |
| “Health workers and burial teams spread the disease.” | No. Safe burials, isolation, protective equipment and entry screening are meant to limit transmission. According to ECDC, false accusations led to security incidents in Ituri, which can thereby worsen the epidemic response. |
| “Ebola is already spreading across Europe.” | Not according to the available sources. The French case was imported, and the Frankfurt patient was infected in the DRC and medically evacuated under controlled conditions. This is not community transmission in Europe. |
Source for the new prophylaxis claim: ALIMA / INRB / ANRS MIE: EBO-PEP trial launch, 14 July 2026.
New sources: UNICEF: May U-Report survey, published 13 July 2026, US CDC: patient infected in the DRC, 10 July 2026, German BMG: Frankfurt, 13 July 2026 and University of Oxford: Phase I trial of the ChAdOx1 BDBV candidate vaccine, 13 July 2026.
Main sources: Konrad-Adenauer-Stiftung: health disinformation playbook, Gavi/VaccinesWork: fighting rumours in the DRC, ActionAid: myths and misinformation in Ituri, AFP Fact Check: unproven treatment claims, WHO daily epidemiological update 20260824, WHO AFRO report 15, ECDC outbreak page, checked 26 August 2026 and the complete source inventory.